Primary Cutaneous Neutrophilic Disorders

Primary Cutaneous Neutrophilic Disorders

November 24, 2014 at 9:48 AM 0 comments

Victoria J. Hogarth,1 *Bláithín Moriarty2 1. Department of Dermatology, King’s College Hospital NHS Foundation Trust, London, UK 2. St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK *Correspondence to blaithin.moriarty@gmail.com Disclosure: No potential conflict of interest. Received: 06.05.14 Accepted: 15.09.14 Citation: EMJ Dermatol. 2014;2:71-76. AbstractRead More

Neutrophilic Dermatoses Revisited

Neutrophilic Dermatoses Revisited

November 24, 2014 at 9:41 AM 0 comments

*Aristóteles Rosmaninho,1 Sandrina Carvalho,2 Inês Lobo2 1. Dermatology Department, Unidade Local de Saúde Alto Minho, EPE, Viana do Castelo, Portugal 2. Dermatology Department, Centro Hospitalar Porto-EPE, Porto, Portugal *Correspondence to arisrosmaninho@gmail.com Disclosure: No potential conflict of interest. Received: 24.07.14 Accepted: 15.09.14 Citation: EMJ Dermatol. 2014;2:77-85. Abstract The neutrophilic dermatoses (ND)Read More

Skin pH in the Elderly and Appropriate Skin Care

Skin pH in the Elderly and Appropriate Skin Care

November 24, 2014 at 9:34 AM 0 comments

Stephan Schreml,1 Michael Kemper,2 *Christoph Abels2 1. Department of Dermatology, University Medical Center Regensburg, Regensburg, Germany 2. Dr. August Wolff GmbH & Co. KG Arzneimittel, Bielefeld, Germany *Correspondence to christoph.abels@wolff-arzneimittel.de Disclosure: M.K. & C.A. are employees of Dr. August Wolff GmbH & Co. KG Arzneimittel which is developing and marketingRead More

Isotretinoin and Psychiatric Effects

Isotretinoin and Psychiatric Effects

November 24, 2014 at 9:25 AM 0 comments

Zennure Takci,1 *AyseSerap Karadag,2 Hatice Burakgazi Yilmaz3 1. Department of Dermatology, School of Medicine, Gaziosmanpasa University, Tokat, Turkey 2. Department of Dermatology, School of Medicine, Istanbul Medeniyet University, Istanbul, Turkey 3. Department of Psychiatry, Cooper Medical School of Rowan University, Camden, New Jersey, USA *Correspondence to karadagaserap@gmail.com Disclosure: No potentialRead More

Methylisothiazolinone and Methylchloroisothiazolinone: New Insights

Methylisothiazolinone and Methylchloroisothiazolinone: New Insights

November 24, 2014 at 9:21 AM 0 comments

*Ana Rita Rodrigues-Barata, Luis Conde-Salazar Contact Dermatitis Unit, Department of Dermatology, Grupo Dermatología Pedro Jaén, Madrid, Spain *Correspondence to rita.rodrigues.md@gmail.com Disclosure: No potential conflict of interest. Received: 25.04.14 Accepted: 29.07.14 Citation: EMJ Dermatol. 2014;2:101-105. Abstract Methylisothiazolinone (MI), along with Kathon™ CG (methylchloroisothiazolinone/MI), are widely used preservatives to prevent bacterial overgrowthRead More

Gram-Negative Bacterial Toe Web Intertrigo

Gram-Negative Bacterial Toe Web Intertrigo

November 24, 2014 at 9:16 AM 0 comments

*Laura Atzori, Myriam Zucca, Michela Lai, Monica Pau Department of Dermatology, University of Cagliari, Cagliari, Italy *Correspondence to atzoril@unica.it Disclosure: No potential conflict of interest. Received: 28.04.14 Accepted: 22.08.14 Citation: EMJ Dermatol. 2014;2:106-111. Abstract Gram-negative infection of the toe web space is less frequent than dermatophytes and yeasts, but itRead More

Xeroderma Pigmentosum – A Multidisciplinary Approach

Xeroderma Pigmentosum – A Multidisciplinary Approach

December 11, 2013 at 11:11 PM 0 comments

Mieran Sethi,1 Alan R. Lehmann,1,2 Hiva Fassihi1 1. National Xeroderma Pigmentosum Service, Department of Photodermatology, St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Trust, London, UK 2. Genome Damage and Stability Centre, University of Sussex, Falmer, Brighton, UK Disclosure: No potential conflict of interest. Received: 01.10.2013 Accepted: 06.11.13 Citation:Read More

Resistance to Targeted Therapies in Melanoma – New Insights

Resistance to Targeted Therapies in Melanoma – New Insights

November 19, 2013 at 10:47 PM 0 comments

Giuseppe Palmieri,1 Maria Colombino,1 Maria Cristina Sini,1 Antonella Manca,1 Paolo Antonio Ascierto,2 Antonio Cossu3 1. Institute of Biomolecular Chemistry, National Research Council, Region Baldinca, Sassari, Italy 2. National Cancer Institute “G. Pascale” Foundation, Napoli, Italy 3. University Hospital, Sassari, Italy Disclosure: Paolo Antonio Ascierto is a consultant of Bristol Myers Squibb,Read More

Skin Reactions Secondary to Anticancer Agents

Skin Reactions Secondary to Anticancer Agents

November 11, 2013 at 10:52 PM 0 comments

Gabriella Fabbrocini,1 Rosanna Izzo,2 Luigia Panariello,3 Giuseppe Monfrecola4 1. Associate Professor, Venereal and Cutaneous Diseases, Division of Dermatology and Venereology, Department of Clinical Medicine and Surgery, University of Naples ‘Federico II’, Italy 2. Doctor, Department of Clinical Medicine and Surgery, University of Naples ‘Federico II’, Italy 3. Specialist, Clinical Dermatology, UniversityRead More

Psoriasis and Comorbidities

Psoriasis and Comorbidities

October 25, 2013 at 11:16 PM 0 comments

Arzu Kılıç, Seray Cakmak Associate Professor, Ankara Numune Education and Research Hospital, Dermatology Clinic, Ankara, Turkey Disclosure: No potential conflict of interest. Received: 20.08.13 Accepted: 25.10.13 Citation: EMJ Dermatol. 2013;1:78-85. Abstract Psoriasis is a chronic inflammatory disease which is a result of complex interactions between genetic, environmental, and immunological factors.Read More